1. Zhang, Min, Hu, Shuofeng, Min, Min, Ying, Xiaomin, Liu, Yan. 2020. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing. In Gut, 70, 464-475. doi:10.1136/gutjnl-2019-320368. https://pubmed.ncbi.nlm.nih.gov/32532891/
2. Kong, Hyun Kyung, Yoon, Sukjoon, Park, Jong Hoon. 2012. The regulatory mechanism of the LY6K gene expression in human breast cancer cells. In The Journal of biological chemistry, 287, 38889-900. doi:10.1074/jbc.M112.394270. https://pubmed.ncbi.nlm.nih.gov/22988241/
3. Matsuda, R, Enokida, H, Chiyomaru, T, Seki, N, Nakagawa, M. 2010. LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling. In British journal of cancer, 104, 376-86. doi:10.1038/sj.bjc.6605990. https://pubmed.ncbi.nlm.nih.gov/21063397/
4. Sastry, Namratha G, Wan, Xuechao, Huang, Tianzhi, Hu, Bo, Cheng, Shi-Yuan. . LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement. In Neuro-oncology, 22, 1315-1326. doi:10.1093/neuonc/noaa032. https://pubmed.ncbi.nlm.nih.gov/32055849/
5. Ali, Mohamad Moustafa, Di Marco, Mirco, Mahale, Sagar, Kanduri, Meena, Kanduri, Chandrasekhar. 2021. LY6K-AS lncRNA is a lung adenocarcinoma prognostic biomarker and regulator of mitotic progression. In Oncogene, 40, 2463-2478. doi:10.1038/s41388-021-01696-7. https://pubmed.ncbi.nlm.nih.gov/33674747/
6. Benti, Senyi, Tiwari, Purushottam B, Goodlett, Dustin W, Shimizu, Linda S, Upadhyay, Geeta. 2020. Small Molecule Binds with Lymphocyte Antigen 6K to Induce Cancer Cell Death. In Cancers, 12, . doi:10.3390/cancers12020509. https://pubmed.ncbi.nlm.nih.gov/32098321/
7. Kong, Hyun Kyung, Park, Sae Jeong, Kim, Ye Sol, Jang, Kyu Yun, Park, Jong Hoon. . Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma. In Oncotarget, 7, 55677-55689. doi:10.18632/oncotarget.10972. https://pubmed.ncbi.nlm.nih.gov/27494879/
8. Guo, Dandan, Liu, Yujia, Jiang, Yuchen, Huang, Ping, Zhang, Yiwen. . A narrative review of the emerging role of lymphocyte antigen 6 complex locus K in cancer: from basic research to clinical practice. In Annals of translational medicine, 10, 26. doi:10.21037/atm-21-5831. https://pubmed.ncbi.nlm.nih.gov/35242871/
9. AlHossiny, Midrar, Luo, Linlin, Frazier, William R, Kumar, Rakesh, Upadhyay, Geeta. 2016. Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance. In Cancer research, 76, 3376-86. doi:10.1158/0008-5472.CAN-15-2654. https://pubmed.ncbi.nlm.nih.gov/27197181/
10. Son, Dasom, Kong, Hyun-Kyung, Kim, Yesol, Lee, Han Woong, Park, Jong Hoon. 2018. Transgenic overexpression of human LY6K in mice suppresses mature T cell development in the thymus. In Oncology letters, 17, 379-387. doi:10.3892/ol.2018.9548. https://pubmed.ncbi.nlm.nih.gov/30655778/